Namikawa R, Weilbaecher K N, Kaneshima H, Yee E J, McCune J M
SyStemix, Inc., Palo Alto, California 94303.
J Exp Med. 1990 Oct 1;172(4):1055-63. doi: 10.1084/jem.172.4.1055.
Coimplantation of small fragments of human fetal thymus and fetal liver into immunodeficient SCID mice resulted in the formation of a unique structure (Thy/Liv). Thereafter, the SCID-hu mice showed reproducible and long-term reconstitution of human hematopoietic activity. For periods lasting 5-11 mo after transplantation, active T lymphopoiesis was observed inside the grafts and cells that were negative for T cell markers were found to have colony-forming units for granulocyte/macrophage (CFU-GM) and erythroid burst-forming unit (BFU-E) activity in the methylcellulose colony assay. In addition, structures similar to normal human bone marrow were observed inside the Thy/Liv grafts, consisting of blast cells, mature and immature forms of myelomonocytic cells, and megakaryocytes. These data indicate long-term maintenance, in vivo, of human progenitor cells for the T lymphoid, myelomonocytic, erythroid, and megakaryocytic lineages. The role of the implanted fetal liver fragments was analyzed using HLA-mismatched Thy/Liv implants. The HLA type of the liver donor was found on T cells and macrophages in the graft. In addition, cells grown in the methylcellulose colony assay and cells in a bone marrow-like structure, the "thymic isle," expressed the HLA type of the liver donor. Thus, the Thy/Liv implants provided a microenvironment in which to follow human hematopoietic progenitor cells for multiple lineages. The formation of the Thy/Liv structures also results in a continuous source of human T cells in the peripheral circulation of the SCID-hu mouse. Though present for 5-11 mo, these cells did not engage in a xenograft (graft-versus-host) reaction. This animal model, the first in which multilineage human hematopoietic activity is maintained for long periods of time, should be useful for the analysis of human hematopoiesis in vivo.
将人胎儿胸腺和胎儿肝脏的小片段共同植入免疫缺陷的重症联合免疫缺陷(SCID)小鼠体内,导致形成了一种独特的结构(胸腺/肝脏结构)。此后,SCID-hu小鼠表现出可重复的、长期的人造血活性重建。在移植后持续5至11个月的时间段内,在移植物内部观察到活跃的T淋巴细胞生成,并且在甲基纤维素集落测定中发现,T细胞标志物阴性的细胞具有粒细胞/巨噬细胞集落形成单位(CFU-GM)和红系爆式集落形成单位(BFU-E)活性。此外,在胸腺/肝脏移植物内部观察到类似于正常人骨髓的结构,由原始细胞、成熟和未成熟形式的骨髓单核细胞以及巨核细胞组成。这些数据表明,人T淋巴细胞、骨髓单核细胞、红系和巨核细胞谱系的祖细胞在体内能够长期维持。使用HLA不匹配的胸腺/肝脏移植物分析了植入的胎儿肝脏片段的作用。在移植物中的T细胞和巨噬细胞上发现了肝脏供体的HLA类型。此外,在甲基纤维素集落测定中生长的细胞以及骨髓样结构“胸腺岛”中的细胞表达了肝脏供体的HLA类型。因此,胸腺/肝脏移植物提供了一个微环境,可在其中追踪多种谱系的人造血祖细胞。胸腺/肝脏结构的形成还导致SCID-hu小鼠外周循环中持续存在人T细胞来源。尽管这些细胞存在5至11个月,但它们并未引发异种移植(移植物抗宿主)反应。这种动物模型是首个能够长期维持多谱系人造血活性的模型,应该有助于体内人造血作用的分析。